GTC presented abstracts at the 2025 Annual Meeting of the Society for Neuro-Oncology (SNO).
GTC participated in the 30th Annual Meeting & Education Day of the Society for Neuro-Oncology (SNO), held at the Hawaii Convention Center in Honolulu, November 19–23, 2025. Our two presented posters are now available for download. For scientific clarification or collaboration inquiries, please contact us directly.
Using cell free DNA (cfDNA) and RNA (cfRNA) in the diagnosis and monitoring of primary and metastatic CNS tumors - Abstract Code: INNV-08
Monitoring therapy in leptomeningeal carcinomatosis in colorectal cancer using CSF liquid biopsy.- Abstract Code: BIOM40
Read more Articles and News from GTC
New Paper Highlights the Critical Role of GTC’s Molecular Testing in CTCL
Dr. Maher Albitar of Genomic Testing Cooperative is among the study’s co-authors. Read the publication in Modern Pathology DOI: 10.1016/j.modpat.2026.101054Published online: August 13, 2026.
Using cell-free RNA to identify B- and T-cell clonality for diagnosis and monitoring of B- and T-cell neoplasms
New Paper published in FEBS openbio Cell-free RNA (cfRNA) is emerging as a supplemental approach for liquid biopsy (LBx). Given that lymphoid cells and plasma
Biology-based multi-class classification of cancer using genomics and artificial intelligence
Abstract Cancer classification traditionally focuses on tissue of origin and histology appearance. Traditional “hard” classification for a specific diagnostic class yields binary yes/no class prediction.